Dalacin C 300 mg (PI Pharma) hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dalacin c 300 mg (pi pharma) hard caps.

pi pharma sa-nv - clindamycin hydrochloride 355,03 mg - eq. clindamycin 300 mg - capsule, hard - clindamycin

Dalacin C 150 mg Namibia - English - Namibia Medicines Regulatory Council

dalacin c 150 mg

pfizer laboratories (pty) ltd - clindamycin hydrochloride - capsule - 150mg

DALACIN C 300MG CAPS Capsule, hard Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

dalacin c 300mg caps capsule, hard

pfizer holding france, france - clindamycin hydrochloride - capsule, hard - 300 mg

DALACIN C 150 MG CAPS Capsule, hard Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

dalacin c 150 mg caps capsule, hard

pfizer holding france, france - clindamycin hydrochloride - capsule, hard - 150 mg

Dalacin C Capsules Australia - English - Department of Health (Therapeutic Goods Administration)

dalacin c capsules

pfizer australia pty ltd - clindamycin hydrochloride -

Dalacin C Phosphate Injection Australia - English - Department of Health (Therapeutic Goods Administration)

dalacin c phosphate injection

pfizer australia pty ltd - clindamycin phosphate -

Dalacin T Lotion Australia - English - Department of Health (Therapeutic Goods Administration)

dalacin t lotion

pfizer australia pty ltd - clindamycin -

Dalacin V Australia - English - Department of Health (Therapeutic Goods Administration)

dalacin v

pfizer australia pty ltd - clindamycin phosphate -

Dalacin C New Zealand - English - Medsafe (Medicines Safety Authority)

dalacin c

pfizer new zealand limited - clindamycin phosphate 178.22 mg/ml equivalent to clindamycin base 150 mg/ml;  ;  ;   - solution for injection - 600mg/4ml - active: clindamycin phosphate 178.22 mg/ml equivalent to clindamycin base 150 mg/ml       excipient: benzyl alcohol disodium edetate dihydrate hydrochloric acid sodium hydroxide water for injection - clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.

DALACIN T TOPICAL GEL 1% Singapore - English - HSA (Health Sciences Authority)

dalacin t topical gel 1%

pfizer private limited - clindamycin phosphate eqv clindamycin - gel - 1.00% - clindamycin phosphate eqv clindamycin 1%